Shenzhen MagicRNA Biotechnology Co., Ltd
Shenzhen MagicRNA Biotechnology Co., Ltd
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG) | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Not yet recruiting | Phase 1 | 2026-08-12 | NCT07556120 | |
| Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, skin disorder, systemic lupus erythematosus, systemic sclerosis | Not yet recruiting | Phase 1 | 2026-08-12 | NCT07523282 | |
| Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, diffuse scleroderma, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, scleroderma, skin disorder, systemic lupus erythematosus, systemic sclerosis | Recruiting | Phase 1 | 2026-08-12 | NCT06801119 | |
| Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Not applicable | 2026-03-18 | NCT07413835 |